Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized human albumin therapy in cirrhosis with ascites
NL-OMON59785Phase 3Withdrawn
- Sponsor
- University Hospital Odense
- Start
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of albumin (human) in Cirrhosis, sponsored by University Hospital Odense. Primary endpoint: Cumulative number of liver-related clinical outcomes. Planned start Sep 2022; status: withdrawn.
02
Drugs
albumin (human)
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NL-OMON59785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59785.